Pmsf, SV, CO Flashcards

1
Q

Pmsf

A

Mean Systemic Filling Pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Definition of Pmsf

A

System‐wide equilibrated pressure after cardiac arrest (usually about 10–15mmHg)
o Very similar to postcapillary venous pressure in an animal with a beating heart
o Represented by P1 in Flow = (P1-P2)/R, R = resistance to flow (Ohm’s Law)
o Rewritten: as venous return = (Pmsf – CVP)/venous resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Three methods for determining Pmsf

A
  1. Inspiratory Hold Maneuver
  2. Mathematical Modeling
  3. Tourniquet Technique
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Inspiratory Hold Maneuver

A

series of inspiratory hold maneuvers at Paw 5, 15, 25, 35 cmH2O + simultaneous CVP, CO measurements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Tourniquet Technique

A

rapidly inflating tourniquet (to provide stop-flow event) applied to appendage with preplaced AC or VC attached to pressure-measuring device
 20-30s: ABP, VBP equilibrated – pressure ~ Pmsf

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Use of Pmsf

A

Characterizes functional status of circulating blood volume, identify hypovolemic patients who would benefit from fluid therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Measurements Obtained Using Pmsf

A

Venous return (assumed = CO), Pmsf, CVP measurements used to calculate venous resistance

total systemic compliance calculated from a known volume load, pre/post‐Pmsf measurements.

Functional estimate of Pmsf, circulating BV derived from fact that PPV impedes intrathoracic venous return, diastolic heart filling, SV

Magnitude of SV decrease by PPV used as index of central blood volume
–Magnitude of thoracic BF impairment depends on peak Paw, inspiratory time, cycle rate (essentially pulse pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Magnitude of decrement in SV assessed by:

A

 Systolic blood pressure
 Mean blood pressure
 Pulse pressure (systolic – diastolic pressure)
 Digital evaluation of pulse quality (area under pulse pressure waveform)
 Plethysmographic monitoring of area under PP waveform, caused by inflating lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Limitations of Pmsf

A

Only intended for use in patients with normal lungs, closed chest
 Diffuse disease decreases compliance (change in V/change in P) – diminishes transfer of pressure from airways to pleural space – diminishes magnitude of thoracic blood flow impairment to given ventilator pressure setting

Area under pulse pressure waveform decrements of >10–13% were reported to predict hypovolemia and fluid bolus responsiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Stroke Volume Measurements

A
  1. Estimation by Doppler
  2. Area under PP waveform
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

SV: Doppler measurements

A

o Ventricular end‐diastolic diameter (EDD), ventricular end‐systolic diameter (ESD) measured; end‐diastolic volume (EDV), end‐systolic volume (ESV) calculated
o SV calculated as difference btw EDV, ESV
o Calculated by measuring flow velocity through structure (often aortic valve) of known diameter
o CT, MRI - primarily research tools in anesthetized patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SV: Area under PP waveform - partial correlation: qualitative characterization

A

 Tall wide (bounding) pulse likely associated with large SV
 Short, narrow or thready pulse likely associated with small SV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Arterial Compliance

A

At given arterial compliance, assoc btw change in area under PP wave form, SV
 Basis for most cardiac output measuring devices
 When compliance or impedance changes, qualitative relationship btw PP waveform, SV also changes

Commercial measurement devices usually require intermittent resetting of computation constant to account for changes in compliance, flow impedance DT retrograde reflected pressure waves over time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cardiac Output

A

vol of blood ejected from each ventricle per minute, L/min, product of HR*SV
o CI = cardiac index, CO/BSA or BW – L/min/m2 or L/min/kg
o Summarizes in single value contribution of CV system to global DO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Advantages of CO Monitoring

A

monitoring hemodynamic changes, assessing effectiveness of fluid responsiveness
o Trends > actual values, ‘functional CO monitoring’ – positive response = acute increase 20-25%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

5 Primary Variables of CO

A

o HR
o Rhythm
o Preload
o Contractility
o Afterload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Basic Principles of CO Measurement

A

o Results obtained must be of clinical relevance to patient
o Data obtained must be sufficiently accurate
o Therapeutic intervention must improve outcome
o Patient’s BP: important, complementary info

Low CO in hypotensive patient: hypovolemia, decreased cardiac function
High CO in hypotensive patient: decreased SVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which is the only technique that allows for direct CO measurement?

A

electromagnetic flowmetry

Requires sx implantation of flow probe circumferentially to main PA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Fick’s Principle for CO

A

1870 – first technique to measure CO
o Measurement of CaO2, CvO2, O2 consumption
 Measurement of O2 consumption = limitation of technique, requires accurate collection/analysis of exhaled gases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the reference standard for CO monitoring?

A

PAC thermodilution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Law of Conservation of Mass and the Fick Principle

A

Law of Conservation of Mass: quantity of O2, CO2 leaving lungs = quantity of gas taken up or expelled by blood flowing in pulmonary circulation
 Limitation: absence of any CP shunting

Requires PA cath for MvB sampling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Modified Fick Technique

A

estimates for VO2

CO = VO2/(CaO2-CvO2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Indirect Fick Method of Measuring CO: NICO

A

MOA: Elimination of CO2 rather than uptake of O2

Intermittent periods of partial rebreathing – estimates PaCO2, PvCO2 from ETCO2 partial pressure during normal breathing and rebreathing
* VCO2 calculated from minute ventilation, CO2 content
* CaCO2 estimated from ETCO2
*PvCO2 ~ CvCO2 (blood draw)

Essentially CO = (VCO2)/(CVCO2-CaCO2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Equilibrium Point Assoc with Indirect Fick Method

A

CO2 elimination from lungs approaches 0, PvCO2 (end pulmonary capillary blood) = PETCO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How estimate cardiopulmonary shunting with indirect Fick principle?

A

Estimated via FIO2, SpO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Summary of Indirect Fick Principle (NICO Unit)

A

–Essentially rate of CO2 elimination proportional to O2 consumption

–CO = rate of CO elimination (ETCO2)/(CvCO2-CaCO2) comparing normal breathing and rebreathing

Change in CO2 elimination/ETCO2 change IRT rebreathing

–Q3min: rebreathing valve prevents normal volumes of CO2 from being eliminated, patient’s inhaled/exhaled gases diverted through NICO loop for 50s

–CO2 elimination drops, [CO2] in PA increases but CO unchanged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Limitations of NICO

A

–ETT/CMV – need for constant CO2 removal precludes use in SpV with SA patients
–CMV >200mL/kg (12mL/kg so need p >20kg)
–Assumes perfect distribution with no shunting
–Cumbersome calculations, multiple levels of inaccuracy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Advantages of the NICO unit

A

No PAC
No invasive blood gas sampling

29
Q

Accuracy of the NICO/Indirect Fick Principle in Dogs, Horses

A
  • VT 12mL/kg: good correlation with thermodilution, lithium dilution
30
Q

Dye Dilution

A

o Stewart, Hamilton: estimation of CO by knowing amount of injected indicator, calculating area under dilution curve measured downstream
 Same reliability as Fick technique, better suitable in clinical setting
 Became accepted method of reference

31
Q

Thermodilution

A

o Same principles as dye dilution, heat as indicator
o Advantage: less accumulation since thermal

New gold standard

32
Q

Swan Gantz Catheter

A
  • Catheterization of RH by balloon-tipped catheter

–Proximal injection port in RA (~30cm), usually blue - CVP; thermodilution
–Proximal infusion port in distal RA (~31cm), - inj drugs, IVF
–Balloon: usually red
–Thermistor port for thermistor measurements in PA (~4cm)
–Distal PA, pressure transducer and MvB sampling

33
Q

MOA Thermodilution

A

Indicator bolus: sterile saline (known vol, temp) injected into RA via SG PAC – change over time in blood temp in main PA used to calculate CO

Changes in blood temp detected by thermistor at distal end of PA catheter

Computer acquires thermodilution curve over time

Inj 2x, consistent phase of resp cycle – traditionally end of expiration

34
Q

Thermodilution Injectate Characteristics

A

 High volumes, lower temps: most accurate

35
Q

Stewart Hamilton Equation (Simplified)

A

CO = (mg of dye injected * 60)/(avg concentration of dye * time)

36
Q

How does CO affect AUC?

A

CO inversely proportional to derivative of derivative of temp dt
 Low CO: bolus diffuses in RV, PA slowly – larger AUC
 High CO: bolus diffuses more quickly – smaller AUC

37
Q

Limitations of Dye and Thermodilution Techniques

A

no real time values, rapid accumulation of indicator clouds results with serial comparisons, cumbersome calibration (dye techniques), significant quantities of blood required for sampling
 SG = primarily human products, narrow applicable sizes in vet med

38
Q

Sources of Error with Dye and Thermodilution Techniques

A

Lower vol injected than entered: smaller AUC, CO falsely high

Lower temp: change in temp artificially large, CO falsely low

39
Q

Complications Assoc with PAC Placement

A

10% human patients – arrhythmias, heart block, rupture of RH/PA, thromboembolism, pulmonary infarction, valvular damage, endocarditis

40
Q

Transpulmonary Thermodilution, US Indicator Dilution: PiCCO, COstatus

A

Does not require PAC, same basic principles as PAC thermodilution

Estimation of CO via central venous, arterial catheter only (dedicated femoral AC)

41
Q

PiCCO

A

 Inj of ice-cold IVF, measures changes in temp over time by arterial thermistor tipped catheter in femoral artery

42
Q

COstatus

A

Changes in blood viscosity following inj of small saline bolus (0.5-1mL/kg) warmed to room temp – changes in US velocity, quantified, measured

Roller pump, extracorporeal AV loop btw peripheral AC, distal lumen of CVC

Two reusable sensors: measure change in US velocity, BF through AV loop

SV derived from dilution curves

43
Q

COstatus sensors

A
  1. Venous sensory
  2. Arterial sensory
44
Q

Venous sensory for COstatus

A

inj of saline, records time/vol of inj

45
Q

Arterial Sensory for COstatus

A

changes in concentration of saline in blood as a dilution, indicator travel time

46
Q

COstatus Accuracy/Limitations

A

Good agreement in humans, +volumetric variables, no specific equipment for veterinary patients, more user friendly

COstatus: accurate, safe in patients <1kg
 Restricted to patients <250kg

47
Q

Lithium Dilution (LiDCO)

A

Dye dilution CO monitoring: IV injection of isotonic lithium chloride (0.002-0.004mmol/kg) as indicator
o [Lithium] in blood – lithium selective electrode connected to peripheral AC
o Lithium [ ] vs time curve via 4.5mL/min blood draw through disposable sensor
 Computer converts voltage signal across lithium-selective membrane to [lithium]

48
Q

Calculation for LiDCO

A

CO = (LiClx60)/[AUC(1-PCV)

PCV correct bc lithium only distributed in plasma, transform into total BF

49
Q

Advantages of LiDCO

A
  • As accurate as PAC thermodilution, more accurate when given via central line vs electromagnetic flowmetry (pigs)
  • Easy to set up, operate
  • Horses, dogs, pigs cats
  • Uses lines already present in critically ill patients (inj via peripheral catheter)
50
Q

Disadvantages of LiDCO

A
  • Poor performance in presence of arrhythmias
  • Interactions btw lithium, some ax drugs (rocuronium)*
  • Blood loss assoc with withdrawal of arterial blood
51
Q

Other Important Feature with CO Monitoring

A

ideally would paralyze patients for CO monitoring bc CO affected by resp, better able to standardize

52
Q

Arterial Waveform Analysis

A

Requires arterial access, estimation of CO by measurement of AUC of pulse wave
 Unreliable in dogs, horses

PiCCO, LiDCO, other devices

53
Q

PiCCO for Arterial Waveform Analysis

A

arterial pulse contour analysis
 Requires calibration: transpulmonary thermodilution
 Repeat calibration needed to obtain adequate estimation of CO, whenever change in vasomotor tone/significant change in patient’s condition

calibration prior to CO measurement based on assumption that SV = sum of systolic, diastolic flows

Systolic, diastolic flows proportional to systolic, diastolic areas in AP waveform

54
Q

LiDCO for Arterial Waveform Analysis

A

pulse power analysis for beat to beat estim of CO
 Calibration via lithium dilution

calibration prior to CO measurement based on assumption that SV = sum of systolic, diastolic flows

Systolic, diastolic flows proportional to systolic, diastolic areas in AP waveform

55
Q

Other Devices for Arterial Waveform Analysis

A

no baseline calibration, empirically calculate SV
 Accuracy, precision questionable
 Technical difficulties

56
Q

Advantages of Echo/Doppler Based Techniques for CO Measurement

A

large amt of hemodynamic info obtained – contractility, chamber filling, assessment of valves/pericardium

57
Q

Non-Doppler techniques for CO Measurements

A

 Based on approximate volumetric reconstructions of LV chamber
 Simpson’s rule: LV divided into series of disks stacked from base to apex
* LV volume: summing approximated volumes of individual disks
* SV: determining difference in vol btw systole, diastole

58
Q

Simpson’s Rule for Non-Doppler Measurements of CO

A

LV divided into series of disks stacked from base to apex
* LV volume: summing approximated volumes of individual disks
* SV: determining difference in vol btw systole, diastole

59
Q

Disadvantages of Non-Doppler Techniques for Measurement of CO

A

Disadvantages: time consuming, inadequate for rapid assessment

Rarely used clinically

60
Q

Doppler for CO Measurement

A

Transthoracic, transesophageal – Doppler measurement of flow

Doppler Effect: shift in frequency as US beam directed along aorta, part of signal reflected back by moving RBCs at different frequency
* Determination of flow velocity

61
Q

MOA Doppler for CO Measurement

A

measure cross sectional area (CSA) of LVOT, essentially a circle = (pi)r2
* CO = HR x CSA x VTI
* VTI = velocity time integral, represents distance that blood travels during one beat, ‘stroke distance’
* Subcostal view for SA – three or four chambered views, perfect parallel alignment of Doppler with LVOT

62
Q

Advantages of Doppler for CO Measurement

A

Acceptable alternative to thermodilution for clinical purposes

63
Q

Disadvantages of Doppler for CO Measurement

A

Not appropriate for continuous CO measurements – heat-induced injury

Expertise required: veterinary cardiologists, equipment

Image quality, sample site, angle of insonation, velocity signal to noise ratio, shape of aortic valve, ability to measure LVOT

64
Q

Bioimpedance

A

changes in conductivity of high frequency, low magnitude alternating current passing across thorax to derive SV

Changes in electrical conductivity produced by variations in intrathoracic blood flow during each cardiac cycle

65
Q

Bioimpedance MOA

A

Electrodes placed on thorax, neck - small, non-painful current passed btw electrodes, change in voltage (bioimpedance) measured

Measurements converted to SV using various equations, algorithms

Real time estimation of SV, CO
* Measures of thoracic fluid content, LV ejection time, SVR, L cardiac work index

66
Q

Bioreactance

A

measures changes in frequency of electrical currents
 Less prone to noise-derived errors

67
Q

Advantages of Bioimpedance, Bioreactance

A

non-invasive, quick application

68
Q

Disadvantages of Bioimpedance, Bioreactance

A

inaccurate in critically ill patients esp in presence of pulmonary edema/pleural effusion; electrical interference
 Little to no evidence in vet med
 Approximation of chest shape as cylinder, cone for SV determination
 Unlikely that human algorithms applicable to veterinary patients